Novartis
To discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering.
Launch date
Employees
Market cap
$233.7b
Enterprise valuation
$254.3b (Public information from Sep 2024)
Share price
$115.97 NVS
Company register number CHE-106.054.058
Basel Canton of Basel-Stadt (HQ)
Corporate Venture Fund: dRx Capital, Novartis Venture Fund
No columns specified